Ferring Pharmaceuticals, Inc.
Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery
- Conditions
- Reducing Time to Vaginal DeliveryInduction of LaborCervical Ripening
- Interventions
- First Posted Date
- 2010-05-21
- Last Posted Date
- 2014-05-01
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 1358
- Registration Number
- NCT01127581
- Locations
- 🇺🇸
University of Kansas School of Medicine, Kansas City, Kansas, United States
🇺🇸Precision Trials, Phoenix, Arizona, United States
🇺🇸University of Cincinnati, Cincinnati, Ohio, United States
A Study of Pentasa in Patients With Ulcerative Colitis
- Conditions
- Ulcerative Colitis
- First Posted Date
- 2010-04-15
- Last Posted Date
- 2011-04-07
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 338
- Registration Number
- NCT01104753
- Locations
- 🇨🇿
Faculty Hospital Bpry Plzeň, Plzeň, Czech Republic
🇨🇿Faculty Hospital U Sv. Anny Brno, Brno, Czech Republic
🇨🇿Investigational site, České Budějovice, Czech Republic
Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2011-11-02
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 89
- Registration Number
- NCT01078753
- Locations
- 🇯🇵
Kansai Medical University Hirakata Hospital, Hirakata, Osaka, Japan
🇯🇵Tamura Children's Clinic, Mito, Ibaraki, Japan
🇯🇵Shinbo Child Clinic, Yokohama, Kanagawa, Japan
Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Day Before PicoPrep
- Conditions
- Bowel Preparation
- Interventions
- First Posted Date
- 2010-02-23
- Last Posted Date
- 2012-10-30
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 603
- Registration Number
- NCT01073943
- Locations
- 🇺🇸
Florida Clinical Research Group, Clearwater, Florida, United States
🇺🇸Gastroenterology Research Consultants of Greater Cincinnati, Cincinnati, Ohio, United States
🇺🇸Investigational site, Hollywood, Florida, United States
Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Split Dose PicoPrep
- Conditions
- Bowel Preparation
- Interventions
- First Posted Date
- 2010-02-23
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 608
- Registration Number
- NCT01073930
- Locations
- 🇺🇸
Louisiana Research Center LLC, Shreveport, Louisiana, United States
🇺🇸Indiana University Hospital, Indianapolis, Indiana, United States
🇺🇸Piedmont Medical Research Associates, Winston-Salem, North Carolina, United States
Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer
- First Posted Date
- 2010-02-19
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 157
- Registration Number
- NCT01071915
- Locations
- 🇰🇷
Pusan National University Yangsan Hospital, Mulgeum-eup, Gyungnam, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Seongnam, Korea, Republic of
Effect of Oxytocin Antagonist on Reduction of Uterine Contractions
- Conditions
- In Vitro Fertilisation (IVF) Treatment
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-01-06
- Last Posted Date
- 2017-06-21
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 99
- Registration Number
- NCT01043120
- Locations
- 🇪🇸
IVI Madrid, Madrid, Spain
🇪🇸IU Dexeus, Barcelona, Spain
🇨🇿IVF Institute, Plzen, Czechia
Effects of the V1a Agonist FE 202158 in Patients With Septic Shock
- Conditions
- Septic Shock
- Interventions
- First Posted Date
- 2009-10-23
- Last Posted Date
- 2017-09-25
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 53
- Registration Number
- NCT01000649
- Locations
- 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
🇧🇪University Hospital Vrije Universiteit, Brussels, Belgium
🇩🇰Hillerød Hospital, Hillerød, Denmark
Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Device: Buffered SalineDevice: 1.2% Sodium Hyaluronate
- First Posted Date
- 2009-10-01
- Last Posted Date
- 2012-06-15
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 596
- Registration Number
- NCT00988091
- Locations
- 🇺🇸
Rx Medical Research of Arkansas, Inc, Little Rock, Arkansas, United States
🇺🇸Holston Medical Group, Kingsport, Tennessee, United States
🇺🇸Omega Medical Research, Warwick, Rhode Island, United States
A Long Term Safety Study of Degarelix in Patients With Prostate Cancer
- First Posted Date
- 2009-08-27
- Last Posted Date
- 2013-01-03
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 77
- Registration Number
- NCT00967018
- Locations
- 🇪🇸
Hospital Universitari Vall d´Hebron, Barcelona, Spain
🇫🇷Centre Paul Strauss, Strassbourg, France
🇧🇪Institut Jules Bordet, Bruxelles, Belgium